Home › Bone Cancer › Texas › Houston
Bone Cancer clinical trials in Houston, TX
5 studies for Bone Cancer are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
RecruitingPhase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
RecruitingObservational study
- MD Anderson Cancer Center, Houston
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
RecruitingPhase 2
- M.D. Anderson Children's Cancer Hospital, Houston
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
RecruitingPhase 1
- Houston Metro Urology, Houston
- Oncology Consultants, Houston
- Excel Diagnostics and Nuclear Oncology Center, Houston
- and 1 more
About Bone Cancer
Bone cancer comes in three types: Osteosarcoma, Chondrosarcoma, and Ewing's sarcoma. Learn how bone cancer is diagnosed and treated.
More about Bone Cancer on MedlinePlus
Bone Cancer trials in other cities
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.